Sofinnova Investments’s Aclaris Therapeutics ACRS Stock Holding History

Sofinnova Investments’s Portfolio ACRS Stock Details ACRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,911,573	Closed	-$12.4M	–	67
2020 Q4	$12.4M	Hold	1,911,573	–	–	0.77%	27
2020 Q3	$4.91M	Hold	1,911,573	–	–	0.38%	46
2020 Q2	$3.1M	Hold	1,911,573	–	–	0.21%	61
2020 Q1	$1.99M	Hold	1,911,573	–	–	0.19%	54
2019 Q4	$3.61M	Hold	1,911,573	–	–	0.27%	50
2019 Q3	$2.06M	Hold	1,911,573	–	–	0.2%	57
2019 Q2	$4.19M	Hold	1,911,573	–	–	0.4%	42
2019 Q1	$11.4M	Hold	1,911,573	–	–	1.17%	19
2018 Q4	$14.1M	Buy	1,911,573 +372,093	+24%	+$3.84M	1.76%	15
2018 Q3	$22.4M	Hold	1,539,480	–	–	2.01%	13
2018 Q2	$30.7M	Hold	1,539,480	–	–	3.53%	9
2018 Q1	$27M	Buy	+1,539,480	New	+$32.6M	4.64%	9

Other funds holding ACRS

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Parkman Healthcare Partners Stamford, Connecticut $965M AUM 79.46% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return